to page content
to site navigation
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
By measuing the cash cycle--the time it takes to receive cash from sales after investing in products/services--entrepreneurs can monitor and improve internal cash flow.
Venture capitalists play a critical funding role, as entrepreneurial ventures move into the big leagues, but the price these investors extract is often too high. Entrepreneurs should consider the relationship analogous to marrying a mail-order bride and proceed accordingly, according to this comprehensive and entertaining article by two women who co-founded a software company. Tips include advising company owners to build trust with VCs and, until that is established, dealing with them in a way that allows for "a reasonable balance of power."
This tool provides a detailed look into the various sections of a cash flow statement. It also describes two methods used to calculate cash flow from operating activities, indirect and direct with examples that will give you an edge when it comes time to preparing a cash flow statement of your own.
Fickle clients, fast growth, creative people -- crazy business! This entrepreneur watched his firm grow swiftly and his financial records become increasingly more complex, all while doing business with people whose first priority was not finishing the project on budget. He shares his experience dealing with creative workers, a quickly growing business, and his solution: strictly managed cash flow.
This article discusses cash and burn rate--that is how efficiently cash is used and how much cash is needed to operate day in and day out.
Entrepreneurs often have only one opportunity to make a good impression on potential investors. Goff includes recommendations to ensure that pitches have a better chance of gaining interest from angel investors.
London's Alternative Investment Market (AIM) is a credible alternative for U.S. companies looking for a market listing. As with any approach to IPO, U.S. companies should research AIM's advantages and disadvantages for listing compared with U.S. stock markets.
The number of life sciences venture deals was down in the third quarter and first-time funding was down as well. Read more about the reasons behind the numbers.
New healthcare business plans can go wrong if the life science company founders don't discuss how they'll split up proceeds and shares of the company. Read what the Kauffman Foundation and other leaders suggest for life science entrepreneurs.
When selling your company be sure you understand the offering price might not match the value of your company and the deal is probably more complex than it seems. Pitfalls include nature of a stock deal, stability of the purchasing company, and tax implications. Best advice: Cash is still king!
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.